| Integrated mental health services in China: challenges and planning for the future D Liang, VM Mays, WC Hwang Health policy and planning 33 (1), 107-122, 2017 | 195 | 2017 |
| High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System YI Hser, LJ Mooney, AJ Saxon, K Miotto, DS Bell, Y Zhu, D Liang, ... Journal of addiction medicine 11 (4), 315-319, 2017 | 178 | 2017 |
| Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993–2014 D Liang, Y Bao, M Wallace, I Grant, Y Shi Addiction 113 (11), 2060-2070, 2018 | 91 | 2018 |
| Public Health Services Utilization and Its Determinants among Internal Migrants in China: Evidence from a Nationally Representative Survey J Zhang, S Lin, D Liang, Y Qian, D Zhang, Z Hou International Journal of Environmental Research and Public Health 14 (9), 1002, 2017 | 71 | 2017 |
| Recreational marijuana legalization and prescription opioids received by Medicaid enrollees Y Shi, D Liang, Y Bao, R An, MS Wallace, I Grant Drug and alcohol dependence 194, 13-19, 2019 | 70 | 2019 |
| Impact of the National Essential Public Health Services Policy on Hypertension Control in China D Zhang, X Pan, S Li, D Liang, Z Hou, Y Li, L Shi American journal of hypertension 31 (1), 115-123, 2017 | 58 | 2017 |
| The associations between prenatal cannabis use disorder and neonatal outcomes Y Shi, B Zhu, D Liang Addiction, 2021 | 54 | 2021 |
| A pilot study of a smartphone application supporting recovery from drug addiction D Liang, H Han, J Du, M Zhao, YI Hser Journal of substance abuse treatment 88, 51-58, 2018 | 47 | 2018 |
| Drug abuse, HIV, and HCV in Asian countries YI Hser, D Liang, YC Lan, BK Vicknasingam, A Chakrabarti Journal of Neuroimmune Pharmacology 11 (3), 383-393, 2016 | 41 | 2016 |
| The association between recreational cannabis commercialization and cannabis exposures reported to the US National Poison Data System Y Shi, D Liang Addiction, 2020 | 40 | 2020 |
| A smartphone application supporting recovery from heroin addiction: perspectives of patients and providers in China, Taiwan, and the USA M Schulte, D Liang, F Wu, YC Lan, W Tsay, J Du, M Zhao, X Li, YI Hser Journal of Neuroimmune Pharmacology 11 (3), 511-522, 2016 | 37 | 2016 |
| 化痰药物氨溴索的非化痰作用研究进展 L Di, W Gui 复旦学报 (医学版) 38 (06), 553-555, 2011 | 32 | 2011 |
| Escalating Opioid Dose Is Associated With Mortality: A Comparison of Patients With and Without Opioid Use Disorder YI Hser, AJ Saxon, LJ Mooney, K Miotto, Y Zhu, CK Yoo, D Liang, ... Journal of Addiction Medicine, 2018 | 25 | 2018 |
| Prescription drug monitoring programs and drug overdose deaths involving benzodiazepines and prescription opioids D Liang, Y Shi Drug and Alcohol Review 38 (5), 494-502, 2019 | 23 | 2019 |
| Medical and non‐medical cannabis use and risk of prescription opioid use disorder: Findings from propensity score matching D Liang, MS Wallace, Y Shi Drug and Alcohol Review, 2019 | 22 | 2019 |
| Building a People-Centred Integrated Care Model in Urban China: A Qualitative Study of the Health Reform in Luohu D Liang, L Mei, Y Chen, P Zhou, X Yang, J Huang International Journal of Integrated Care 20 (1), 2020 | 21 | 2020 |
| Feasibility of a Mobile Phone App to Support Recovery From Addiction in China: Secondary Analysis of a Pilot Study H Han, JY Zhang, YI Hser, D Liang, X Li, SS Wang, J Du, M Zhao JMIR mHealth and uHealth 6 (2), 2018 | 20 | 2018 |
| Economic burden of informal care attributable to stroke among those aged 65 years or older in China H Joo, D Liang International Journal of Stroke 12 (2), 205-207, 2017 | 18 | 2017 |
| Mandatory use of prescription drug monitoring program and benzodiazepine prescribing among US Medicaid enrollees D Liang, H Guo, Y Shi Substance abuse, 1-8, 2019 | 16 | 2019 |
| Hospital Ownership and Hospital Institutional Change: A Qualitative Study in Guizhou Province, China Y Xie, D Liang, J Huang, J Jin International journal of environmental research and public health 16 (8), 1460, 2019 | 13 | 2019 |
